Caribou Biosciences, Inc. [CRBU] - restructuring costs
Caribou Biosciences estimates restructuring expenses of approximately $15 million to $19 million, primarily for severance and healthcare costs, as it plans to discontinue clinical trials and reduce its workforce in response to financing challenges in the CAR-T therapy sector.
Why this matters
Generating analysis…